Abstract
The objective of the research was to identify volumetric brain indicators (hippocampal volume) in patients with chronic cerebral ischemia secondary to metabolic syndrome (MS) in comparison with patients suffering from chronic cerebral ischemia without MS; to identify hippocampal index as well as medial, lateral and upper perihippocampal indices in patients with MS in comparison with those in patients without MS.
Materials and methods. Hippocampal volume of 47 patients (29 patients with MS - the main group and 18 patients without MS – the control group) was evaluated by means of volumetric method. During 49 studies (28 - the main group and 21 - the control group) the size of the hippocampus and perihippocampal cerebrospinal fluid space was measured.
Results and discussion. We determined a significant increase (*P<0.05 in comparison with the control group) in the lateral perihippocampal cerebrospinal fluid space (cm) in the main group in comparison with the control group (Me [Q1, Q3]): on the right it was 2.90 [2.75 ; 2.96] vs. 2.21 [1.82; 2.05] in the control group (р<0.05); on the left it was 2.97 [2.75; 2.96] vs. 2.275 [2.15; 2.76] in the control group (р>0.05). A significant decrease in the index of the right and left hippocampus was determined in patients with MS in comparison to the patients of the control group (Me [Q1,Q3]): on the right it was 0.50 [0.41; 0.54] vs. 0.594 [0.58; 0.61]; on the left it was 0.56 [0.52; 0.60] vs. 0.61 [0.58; 0.63] in the control group (р<0.05). A significant difference in the increase of the medial and upper perihippocampal indices on either side was defined in the main group in comparison with the control one. Lateral perihippocampal index did not significantly differ from the control group (р>0.05). Determination of the hippocampal volume (right and left) showed that it was significantly lower in patients with MS than in patients without MS (Me [Q1,Q3]): on the right it was 3.293058* [2.92616; 3.04016] in the main group, and 3.93 [3.72750; 4.29722] in the control group; on the left it was 2.84 [2.65; 3.02] * in the main group, and 3.55 [3.22, 3.7] in the control group. Components of MS cluster in patients with chronic cerebrovascular pathology are likely to contribute to the development of atrophic processes. The combination of hypertension, insulin resistance, dyslipidemia, etc. accelerate the processes of hippocampal atrophy more than each of these separate components determined in patients with chronic cerebral ischemia without MS.
Conclusions. Thus, the degree of hippocampal atrophy in patients with chronic cerebrovascular diseases secondary to MS was defined to be significantly higher in comparison with patients without MS. To improve diagnosis of cerebrovascular diseases in patients with MS, it is possible to apply the identification of hippocampal index and perihippocampal indices if it is not possible to determine the volume of brain structures.
References
Varakin YuYa, Gornostaeva GV, Kravchenko MA. Peculiarities of identifying patients with initial manifestations of chronic cerebrovascular diseases during checkup. Materialy 14 Mezhdunarodnoy konferentsii “Vozrastnye aspekty nevrologiyi”. 2012;2-5.
Drapkina OP. Specific features of course and treatment of arterial hypertension in elderly patients with metabolic syndrome. Farmateka. 2010;8:39-44.
Yesin RG, Khayrullin IH, Yesin OR. Modern views on the mechanisms of cognitive disorders in diabetes mellitus. Meditsinskiy almanakh. 2013;1(25):135-138.
Korczyn A, Toole DF. Vascular diseases of the brain. Moscow. 2007.
Sergeyev V. Metabolic syndrome: causes, treatment and prevention. Vrach. 2009;2:36-41.
Chazova IE, Mychka VB. Metabolic syndrome. Media Medica. Moscow. 2004;10:47-49.
Hassing LB, Grant MD, Hofer SM, et al. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc. 2004;10:599-607.
Komulainenn P, Lakka TA, Kivipelto M, et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord. 2007;23:29-34.
Pinkston JB, Alekseeva N, Gonzalez Toledo E. Stroke and dementia. Neurol Res. 2009;31:824-831.
Scheltens P, Leys D, Barkhof F. Atrophy of medial temporal lobes on MRI in “Probable” Alzheimer's disease and normal aging: diagnostic value andneuropsychological correlations . J Neurol Neurosurg Psychiatry.1992; 55:967-972.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.